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Giant splenic artery aneurysm associated with
arteriovenous malformation
Aditya Agrawal, MS, FRCS,a Richard Whitehouse, MD, FRCS,b Robert W. Johnson, FRCS,a
and Titus Augustine, MS, FRCS,a Manchester, United Kingdom
Giant splenic artery aneurysms are extremely rare entities that have important clinical implications. The size and the
natural history pose unique challenges in the management of these lesions. We present one such case that was associated
with a primary arteriovenous malformation in the splenic hilum. This is the third largest aneurysm reported in literature
so far and the characteristic feature is that this is the first case of a hilar arteriovenous fistula complicated by formation of
a giant aneurysm and another smaller aneurysm. In our opinion the hilar malformation was congenital in origin and
responsible for the formation of the two aneurysms. We also present an up to date review of literature on this subject.
(J Vasc Surg 2006;44:1345-9.)Splenic artery aneurysms are the most common splanch-
nic artery aneurysms, representing 60% of such lesions.1 They
are also the third most common site of intra-abdominal
aneurysms after the aorta and the iliac arteries.2,3 The
reported risk of rupture of splenic artery aneurysms varies
from 3% to 9.6%. More significantly, 95% of splenic artery
aneurysms discovered during pregnancy are ruptured, re-
sulting in a disproportionately high maternal mortality rate
of 70% and a fetal mortality rate 75%.4-7 Most of these
aneurysms are small and saccular and occur in isolation,
usually at arterial bifurcations. Multiple lesions are seen in
approximately 20% of patients.8 More than 80% are located
in the mid or distal splenic artery.9 The reported incidence
of splenic artery aneurysms at autopsy varies, rising from
0.01% to 0.2% in all age groups to 10.4% in the geriatric
population,10,11 the mean age of presentation being 52
years (range, 2 to 93 years).11
Giant aneurysms have rarely been reported. We present
a patient whose characteristic feature was that the giant
aneurysms were associated with a hilar arteriovenous com-
munication, which in our opinion was congenital in origin.
CASE REPORT
A 34-year-old nulliparous woman presented with a 6-week
history of sharp pain in the left upper quadrant on taking deep
breaths. There was no history of abdominal trauma or previous
surgery. On examination, a huge pulsatile mass was found occupy-
ing the central and left upper abdomen.
An ultrasound scan demonstrated a giant splenic artery aneu-
rysm, and a spiral computed tomographic (CT) scan (Fig 1) before
and after intravenous contrast enhancement demonstrated marked
dilatation of the splenic artery, which then expanded into an
anteriorly situated aneurysmmeasuring approximately 10 14 cm
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then passed on to a further smaller aneurysm with a maximum
diameter of 6 cm. Early enhancement of the splenic and portal
veins and venous collateral vessels between the splenic hilum and
superior mesenteric veins was noted, without significant enhance-
ment of the spleen, indicating an arteriovenous anastomosis in the
splenic hilum. Some calcification was noted in the walls of the
splenic aneurysms.
An aortogramwas performed, and this confirmed the presence
of a giant splenic aneurysm, 15 cm in diameter, arising about 2.5
cm distal to the origin of the common hepatic artery. The splenic
artery beyond this aneurysm was immensely dilated and tortuous,
with a second aneurysm of about 4 cm in diameter close to the
splenic hilum, where venous varicosities were also noted. In addi-
tion, the celiac axis was dilated at its origin to almost the same
diameter as the aorta.
Selective celiac injection (Figs 2 and 3) showed premature filling
of the portal vein through arteriovenous shunting at the hilum,
with arterialization of the splenic and portal veins and of the venous
complexes in the liver. The aneurysmal change was thus probably
secondary to a congenital arteriovenous malformation at the hilum.
A laparotomy was initiated with a transverse rooftop incision.
The enormous aneurysm was immediately apparent, and the sec-
ondary aneurysm was actually 10 cm in diameter. There was a very
pronounced arteriovenous fistula in the hilum of the spleen, and
the spleen was hugely enlarged, with extensive areas of infarction.
The lesser sac was opened by lifting the stomach upwards, and
proximal control was achieved by double ligation and division of
the splenic artery close to its origin. The spleen, the two aneurysms,
and the tail of the pancreas were then resected en bloc (Fig 4).
Pathologic examination of the resected specimen revealed an
intact aneurysmmeasuring 21 11.5 8 cm at its widest, with an
intraluminal thrombus weighing 270 grams. The spleen measured
18  10.5  7.5 cm, and microscopic examination revealed
congestion with large infracted areas and no evidence of vasculitis
or neoplasm.
The patient made an excellent postoperative recovery, which
was uneventful apart from temporary urinary retention due to an
atonic bladder that necessitated intermittent self-catheterization
for a period of 8 weeks.
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Spittel et al2 have estimated the mean size of splenic
artery aneurysms to be 2.1 cm, and they rarely exceed 3 cm.2
Giant aneurysms of the splenic artery (diameter 10 cm)
are exceptional. Only 12 cases have been reported so far
in the English literature (Table).12-21 First reported by
Beaussier in 1770, true aneurysms of the splenic artery have
been associated with a number of conditions, with preg-
Fig 1. Spiral CT images before (A) and after (B) intra
aneurysm containing intraluminal thrombus. There is ea
collateral vessels but no enhancement of the spleen. There
Fig 2. Early arterial phase, selective coeliac axis injection, digital
subtraction angiogram demonstrates large splenic artery aneurysm
containing thrombus (arrowhead).nancy and portal hypertension being the most common.Other conditions include systemic hypertension, athero-
sclerosis, medial fibrodysplasia, systemic infection, and var-
ious congenital diseases. None of these known etiologic
factors was present in our patient. Although atherosclerotic
changes have been noted in up to 99% of the splenic artery
aneurysms examined histologically,1 they most likely repre-
sent a secondary phenomenon8 and the precise mechanism
us contrast enhancement show the giant splenic artery
hancement of splenic and portal veins and of the venous
idence of calcification in the wall of the splenic aneurysm.
Fig 3. Late-phase demonstrating filling of a further aneurysm
above and to the left of the first aneurysm, with multiple vessels
filling around the splenic hilum (arrow) and filling of a dilated
portal vein (arrowhead) and hepatic portal branches.veno
rly enof aneurysm formation is unknown.
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the spleen can cause development of giant splenic artery
aneurysms. Primary hilar arteriovenous malformation lead-
ing to aneurysmal change in the splenic artery has not, to
our knowledge, been previously reported in literature.
There is only one report of a congenital intrasplenic arte-
riovenous communication leading secondarily to splenic
artery aneurysms.22 These aneurysms can rupture, leading
to formation of arteriovenous fistulas. In an extensive re-
view of literature, Brothers et al23 found that 44% of the 91
splenic arteriovenous fistulas reported so far were the result
of ruptured splenic artery aneurysms.
Giant aneurysms appear to be different from common
splenic aneurysms in some important respects. Portal hy-
pertension with splenomegaly and repeated pregnancies
with resultant hormonal and local hemodynamic effects are
considered to be the most significant factors involved in the
pathogenesis of these aneurysmal lesions.
Trastek et al1 found that affected women had had an
average of 4.5 previous pregnancies at the time of diagno-
sis. Portal hypertension was present in as many as 24% of
patients with splenic artery aneurysm,24-26 and they were
Fig 4. Intraoperative picture showing the markedly dilated splenic
artery with two aneurysms and an enlarged spleen.
Table. Splenic artery aneurysms with a diameter larger
than 10 cm reported in literature
Author Year Age Size (cm)
Palmer12 1950 64 15
Becker13 1973 60 15
Becker 1973 74 18
Glover14 1982 27 14
Trastek1 1982 30
Tam15 1988 64 30
Long16 1993 78 16
Kehagias17 1998 37 12
Bornet18 2000 68 11
Pulli19 2001 12.5
Oiu20 2004 73 13
Pescarus21 2005 67 15
Agrawal 2006 34 21noted in 7% to 20% of patients with cirrhosis and portalhypertension.7,27 The incidence in patients with chronic
liver disease who undergo liver transplantation is 10%.28
In the series of patients identified with giant splenic
artery aneurysm, however, only one of the five women was
multiparous, and there was a surprising absence of portal
hypertension in most of the patients: only two of 13 had
portal hypertension. Although large series have shown that
they are four times more common in women, giant splenic
artery aneurysms seem to occur predominantly in men. In
addition, giant lesions tend to be more proximally located
(most commonly in the middle third of the artery), as was
the case in our patient.
Giant splenic artery aneurysms are rarely asymptomatic,
whereas only up to 20% of patients report clinical symptoms
referable to smaller aneurysms, usually in the form of left
upper quadrant or epigastric discomfort or pain. An
abdominal pulsatile mass and bruit are usually present
with giant aneurysms but rarely in common splenic artery
aneurysms.
Aneurysms 2 cm in diameter rarely rupture, but the
risk of rupture for giant splenic artery aneurysms is very
high (28%).18 Severe left upper quadrant pain and shock
indicate aneurysmal rupture, and this has been reported in
2% to 10% of the cases.7,29 Initially, the rupture may be
tamponaded in the lesser omental sac with apparent clinical
stabilization. Eventually the blood escapes into the free
peritoneal cavity, either through the foramen of Winslow
or through rupture of the pars flaccida. This “double
rupture” phenomenon has been reported in 20% to 30% of
ruptured splenic artery aneurysms.24,26,30 Ruptures into a
hollow viscus, the pancreatic duct, or the splenic vein,
resulting in an arteriovenous fistula, have also been de-
scribed. The overall mortality rate of ruptured splenic artery
aneurysms is 10% to 25%.1,7,24
The risk factors for rupture include symptomatic and
large or enlarging aneurysms, pregnancy, portal hyperten-
sion, liver transplantation, and portacaval shunting.31 The
incidence of rupture after liver transplantation is signifi-
cantly high and has led to the recommendation that the
splenic artery be evaluated routinely by Doppler ultrasound
imaging before liver transplantation, so that detected aneu-
rysms can be treated at the time of transplantation.32
In a plain abdominal radiograph, an aneurysm appears
as a curvilinear or signet ring–shaped calcification.3 Simi-
larly, they may be detected incidentally on ultrasonogra-
phy, CT, magnetic resonance imaging, or conventional
arteriography. Arteriography remains the gold standard
technique to precisely define the location of the aneurysm,
assess collateral flow, and identify the presence of other
visceral artery aneurysms.1 Selecting the celiac axis can
elegantly demonstrate arteriovenous shunting from any
malformations, as was seen in this patient. Magnetic reso-
nance and spiral CT angiography are other alternatives.
Symptomatic lesions, aneurysms 2.0 cm, and those
found in pregnant women or women of childbearing age
and in candidates for liver transplantation should all be
treated.7,8,29,30 The aim of treatment is to cut off the blood
supply to the aneurysm. Splenic preservation should always
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is unavoidable when hilar and intrasplenic lesions are en-
countered.30
Giant splenic artery aneurysms offer a great challenge to
the surgeon, as proximal control of the splenic artery can
prove to be extremely difficult. Retroperitoneal access to
the aorta and proximal visceral vessels by medial rotation of
the upper abdominal viscera has been suggested as the best
technique to gain proper exposure and proximal control.16
A thoracoabdominal approach may be required if the an-
eurysm is unusually large.16 The alternative is to exclude
the aneurysm by simple ligation of the splenic artery. The
spleen, with its excellent collateral blood supply, can usually
be preserved.
Methods of laparoscopic exclusion, resection, and re-
pair have all been well described for the treatment of
common splenic artery aneurysms, but to our knowledge,
have not yet been used for the treatment of giant le-
sions.33-35
Nonsurgical endovascular techniques for the treatment
of giant splenic artery aneurysms have been recently de-
scribed, particularly for patients at high risk for operative
repair or those with lesions that are difficult to treat surgi-
cally.36 Percutaneous catheter embolization of giant aneu-
rysms, and even ruptured giant aneurysms, with metal coils,
balloons, and sponges has been reported with favorable
results.37,38
Recent advances in interventional radiology have led to
the use of stent grafts for exclusion of visceral artery aneu-
rysms. This technique allows preservation of a continuous
arterial access to the spleen, which may be used for
subsequent sequential embolization of the organ if nec-
essary (to treat hypersplenism for example).12 Potential
complications include pain and fever, embolism to other
visceral arteries, abscess formation, arterial disruption, con-
trast nephrotoxicity, incomplete occlusion, and recanaliza-
tion. Despite these drawbacks, transcatheter embolization
appears to have a lower incidence of serious complications
compared with surgery, has a success rate of approximately
85%, and may even be considered as a first-line treatment in
appropriate patients.37 The main caveat with these endo-
vascular techniques is that they may be impractical for long
and extremely tortuous lesions.
CONCLUSION
Giant SAAs are very rare and have several important
differences compared with smaller SAAs. The high risk of
rupture demands rapid intervention. Although treatment is
challenging, they can be safely treated surgically by a care-
fully planned approach based on adequate exposure and
proximal and distal arterial control. Advances in endovas-
cular techniques have provided more therapeutic alterna-
tives, especially for high-risk candidates and for aneurysms
that are difficult to treat surgically.
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